Q/C Technologies, Inc.
QCLS- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001321834
No open-market purchases or sales by Q/C Technologies, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $2.87M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Q/C Technologies, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 51 | 50 | −1 |
| Shares | 4.26M | 6.35M | +2.09M (+49.1%) |
| Value | $2.52M | $1.64M | −$881.7K (−35.0%) |
New holders (7)
Institutions that held Q/C Technologies, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 57,718 | $14.9K | 0.00% |
| TCG Advisory Services, LLC | 30,000 | $7.76K | 0.00% |
| Brown Advisory Inc | 16,891 | $4.37K | 0.00% |
| LPL Financial LLC | 13,655 | $3.53K | 0.00% |
| Harbor Investment Advisory, LLC | 2,666 | $690 | 0.00% |
| Arvest Investments, Inc. | 1,000 | $258 | 0.00% |
| Advisory Services Network, LLC | 200 | $52 | 0.00% |
Sold out (8)
Institutions that held Q/C Technologies, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Western Wealth Management, LLC | 25,050 | $14.8K |
| Corundum Group, Inc. | 19,600 | $11.6K |
| Wealth Enhancement Advisory Services, LLC | 18,690 | $11.1K |
| Taylor & Morgan Wealth Management, LLC | 16,086 | $9.52K |
| CI Private Wealth, LLC | 15,300 | $9.06K |
| The PNC Financial Services Group, Inc. | 4,300 | $2.55K |
| WR Wealth Planners, LLC | 1,000 | $592 |
| Federation des caisses Desjardins du Quebec | 500 | $296 |